Drugs / LV-Visio-AMTRIX
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05172349 | Apr → Sep 2022 | corneal ulcer | TBF Genie Tissulaire | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LV-Visio-AMTRIX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05172349 ↗ |
| Modality | Other / unclassified | “Chemically-treated, viro-inactivated, freeze-dried and irradiated allograft” NCT05172349 ↗ |
| Route | Other | “placed by the investigator during patients' hospital visit” NCT05172349 ↗ |